Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Completed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of irinotecan and capecitabine in treating patients who have solid tumors that have not responded to previous treatment.

Key facts

Study ID

NCT00003867

Run by

Montefiore Medical Center

People needed

30

Starts

1999-03-01

Expected to finish

2003-03-01

Last updated by the study team

2018-09-10

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.